Published in Clin Chim Acta on June 18, 2012
The analysis of sialylation, N-glycan branching, and expression of O-glycans in seminal plasma of infertile men. Dis Markers (2015) 1.38
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics (2013) 1.03
Glycoprotein disease markers and single protein-omics. Mol Cell Proteomics (2013) 0.83
Kallikreins - The melting pot of activity and function. Biochimie (2015) 0.82
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes. Theranostics (2016) 0.82
Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors. Open Chem (2015) 0.79
An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis. Int J Mol Sci (2017) 0.77
Sensitive detection and glycoprofiling of a prostate specific antigen using impedimetric assays. Analyst (2015) 0.76
Evaluation of molecular species of prostate-specific antigen complexed with immunoglobulin M in prostate cancer and benign prostatic hyperplasia. Dis Markers (2013) 0.75
Overexpression of Exportin-5 Overrides the Inhibitory Effect of miRNAs Regulation Control and Stabilize Proteins via Posttranslation Modifications in Prostate Cancer. Neoplasia (2017) 0.75
Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med (2008) 11.86
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. Lancet Oncol (2013) 4.55
Testing for recombinant human erythropoietin. J Appl Physiol (1985) (2008) 3.02
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma. J Clin Oncol (2009) 2.88
Erectile implants in female-to-male transsexuals: our experience in 129 patients. Eur Urol (2009) 2.27
Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients. Eur Urol (2009) 2.25
False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood (2006) 2.06
Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant (2005) 1.72
Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc (2002) 1.68
Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol (2006) 1.51
Development of an affordable dye-stained microalbuminuria screening test. Nephrol Dial Transplant (2008) 1.50
Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications. Int J Urol (2014) 1.42
Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer. Prostate (2014) 1.41
Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease. Clin Chem Lab Med (2015) 1.41
EAU guidelines on iatrogenic trauma. Eur Urol (2012) 1.34
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta (2008) 1.23
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. Am J Respir Crit Care Med (2010) 1.14
Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial. BMC Cancer (2014) 1.13
Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy. Clin Genitourin Cancer (2012) 1.11
Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clin Chem (2010) 1.09
Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med (2004) 1.09
Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta (2004) 1.08
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer. Prostate (2014) 1.05
Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol (2012) 1.05
Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia. Clin Chem Lab Med (2011) 1.05
Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int (2009) 1.05
Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Radiother Oncol (2009) 1.01
High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results. Eur Urol (2011) 1.01
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma. J Thorac Oncol (2011) 1.00
Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy. Radiother Oncol (2008) 0.99
Vitamin C deficiency: more than just a nutritional disorder. Genes Nutr (2011) 0.98
Flow cytometry as a new method to quantify the cellular content of human saliva and its relation to gingivitis. Clin Chim Acta (2002) 0.97
Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res (2008) 0.96
Haptoglobin polymorphism and infection. Adv Clin Chem (2010) 0.95
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome. Radiother Oncol (2013) 0.95
Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment. Clin Chem Lab Med (2008) 0.94
Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin Chem (2003) 0.94
Quantitative evaluation of urinalysis test strips. Clin Chem (2002) 0.92
Haptoglobin polymorphism in patients with preeclampsia. Clin Chem Lab Med (2006) 0.92
F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report. J Thorac Imaging (2008) 0.92
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor. Chest (2011) 0.90
Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. J Nephrol (2014) 0.89
Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin Chim Acta (2012) 0.89
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels. PLoS One (2012) 0.89
Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone (2005) 0.89
Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci (2010) 0.88
Glycated nail proteins: a new approach for detecting diabetes in developing countries. Trop Med Int Health (2013) 0.88
The biology of hyperpigmentation syndromes. Pigment Cell Melanoma Res (2014) 0.87
Biologically active, magnICON®-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol (2012) 0.87
Serum free hemoglobin concentrations in healthy individuals are related to haptoglobin type. Clin Chem (2005) 0.86
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study. J Thorac Oncol (2011) 0.86
Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem (2014) 0.86
Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients. Clin Chem Lab Med (2008) 0.85
Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese. Clin Chim Acta (2005) 0.85
Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy. Kidney Int (2003) 0.85
Intraobserver, interobserver, and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinoma. Cancer Biother Radiopharm (2004) 0.84
Reconstruction of the penis after surgery. Urol Clin North Am (2010) 0.84
Urinary beta-trace protein as a new renal tubular marker. Clin Chem (2009) 0.84
Evaluation of Sysmex UF-1000i for use in cerebrospinal fluid analysis. Clin Chim Acta (2008) 0.83
Automated flow cytometry analysis of peritoneal dialysis fluid. Nephrol Dial Transplant (2004) 0.83
Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurovasc Res (2010) 0.83
Creatine supplementation decreases homocysteine in an animal model of uremia. Kidney Int (2003) 0.82
One-stage penectomy and phalloplasty for epithelioid sarcoma of the penis in an adolescent: part 2. Eur Urol (2007) 0.82
Chemiluminescent image detection of haptoglobin phenotyping after polyacrylamide gel electrophoresis. Anal Chem (2004) 0.82
Long term effects of micro-surgical testicular sperm extraction on androgen status in patients with non obstructive azoospermia. BMC Urol (2006) 0.81
Determination of beta2-agonists by ion chromatography with direct conductivity detection. J Pharm Biomed Anal (2005) 0.81
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum. Clin Chem (2009) 0.81
Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol Dial Transplant (2007) 0.81
Proteolysis is a confounding factor in the interpretation of faecal calprotectin. Clin Chem Lab Med (2015) 0.81
Value and pitfalls in iodine fortification and supplementation in the 21st century. Br J Nutr (2011) 0.80
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer. Int J Radiat Oncol Biol Phys (2009) 0.80
Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem (2010) 0.80
Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker. Adv Clin Chem (2013) 0.80
Java project on periodontal diseases: periodontal bone loss in relation to environmental and systemic conditions. J Clin Periodontol (2015) 0.80
Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis. Clin Biochem (2013) 0.79
Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. J Clin Immunol (2013) 0.79
Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer. Adv Urol (2011) 0.79
Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer. Electrophoresis (2013) 0.79
Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy. Radiother Oncol (2013) 0.79
Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation. Is time still on our side? Atherosclerosis (2012) 0.79
Compensating for the influence of total serum protein in the Schwartz formula. Clin Chem Lab Med (2012) 0.78
Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander. Am J Nephrol (2016) 0.78
Chronic nicotine exposure and acute kidney injury: new concepts and experimental evidence. Nephrol Dial Transplant (2013) 0.78
Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma. Oncoimmunology (2012) 0.78
Folates from metabolically engineered rice: a long-term study in rats. Mol Nutr Food Res (2015) 0.78
Complement C3 and its polymorphism: biological and clinical consequences. Pathology (2014) 0.78
Use of nanomaterials in capillary and microchip electrophoresis. Expert Rev Proteomics (2007) 0.78
Iron status in black persons is not influenced by haptoglobin polymorphism. Clin Chem Lab Med (2002) 0.78